Elevated red cell distribution width identifies elevated cardiovascular disease risk in patients with HIV infection

Journal of Acquired Immune Deficiency Syndromes

Volumn 74, Issue 3, 2017, Pages 298-302

  Al Kindi, Sadeer G ^a   Kim, Chang H ^a   Morris, Stephen R ^a   Freeman, Michael L ^b   Funderburg, Nicholas T ^c   Rodriguez, Benigno ^b   McComsey, Grace A ^b   Dalton, Jarrod E ^d   Simon, Daniel I ^a   Lederman, Michael M ^b   Longenecker, Chris T ^a   Zidar, David A ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Cardiovascular disease; Coronary; Heart failure; Peripheral; RDW

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR; INTEGRASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; TENOFOVIR; ZIDOVUDINE; BIOLOGICAL MARKER;

ADULT; AGED; ANEMIA; ARTICLE; ATRIAL FIBRILLATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; FEMALE; HEART FAILURE; HEART INFARCTION; HEMOGLOBINOPATHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASE; PREVALENCE; PRIORITY JOURNAL; RED BLOOD CELL DISTRIBUTION WIDTH; YOUNG ADULT; ADOLESCENT; COHORT ANALYSIS; COMPLICATION; MEAN CORPUSCULAR VOLUME; PATHOLOGY; RISK ASSESSMENT;

ADOLESCENT; ADULT; AGED; BIOMARKERS; CARDIOVASCULAR DISEASES; COHORT STUDIES; ERYTHROCYTE INDICES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; RISK ASSESSMENT; YOUNG ADULT;

EID: 84994558814     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000001231     Document Type: Article

References (37)

1. Zalawadiya SK, Veeranna V, Niraj A, et al. Red cell distribution width and risk of coronary heart disease events. Am J Cardiol. 2010;106:988-993.
2. Wang P, Wang Y, Li H, et al. Relationship between the red blood cell distribution width and risk of acute myocardial infarction. J Atheroscler Thromb. 2015;22:21-26.
3. Borne Y, Smith JG, Melander O, et al. Red cell distribution width and risk for first hospitalization due to heart failure: a population-based cohort study. Eur J Heart Fail. 2011;13:1355-1361.
4. Felker GM, Allen LA, Pocock SJ, et al. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol. 2007;50:40-47.
5. Al-Najjar Y, Goode KM, Zhang J, et al. Red cell distribution width: an inexpensive and powerful prognostic marker in heart failure. Eur J Heart Fail. 2009;11:1155-1162.
6. Oh J, Kang SM, Hong N, et al. Relation between red cell distribution width with echocardiographic parameters in patients with acute heart failure. J Card Fail. 2009;15:517-522.
7. Dabbah S, Hammerman H, Markiewicz W, et al. Relation between red cell distribution width and clinical outcomes after acute myocardial infarction. Am J Cardiol. 2010;105:312-317.
8. Uyarel H, Ergelen M, Cicek G, et al. Red cell distribution width as a novel prognostic marker in patients undergoing primary angioplasty for acute myocardial infarction. Coron Artery Dis. 2011;22:138-144.
9. Tziakas D, Chalikias G, Grapsa A, et al. Red blood cell distribution width: a strong prognostic marker in cardiovascular disease: is associated with cholesterol content of erythrocyte membrane. Clin Hemorheol Microcirc. 2012;51:243-254.
10. Gul M, Uyarel H, Ergelen M, et al. The relationship between red blood cell distribution width and the clinical outcomes in non-ST elevation myocardial infarction and unstable angina pectoris: a 3-year follow-up. Coron Artery Dis. 2012;23:330-336.
11. Allen LA, Felker GM, Mehra MR, et al. Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure. J Card Fail. 2010;16:230-238.
12. Lorente L, Martín MM, Abreu-González P, et al. Red blood cell distribution width during the first week is associated with severity and mortality in septic patients. PLoS One. 2014;9:e105436.
13. Feinstein MJ, Bahiru E, Achenbach C, et al. Patterns of cardiovascular mortality for HIV-infected adults in the United States: 1999 to 2013. Am J Cardiol. 2016;117:214-220.
14. Currier JS, Lundgren JD, Carr A, et al. Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy. Circulation. 2008;118:e29-e35.
15. Dolan SE, Hadigan C, Killilea KM, et al. Increased cardiovascular disease risk indices in HIV-infected women. J Acquir Immune Defic Syndr. 2005;39:44-54.
16. Friis-Møller N, Weber R, Reiss P, et al. Cardiovascular disease risk factors in HIV patients-association with antiretroviral therapy. Results from the DAD study. AIDS. 2003;17:1179-1193.
17. Duprez DA, Neuhaus J, Kuller LH, et al. Inflammation, coagulation and cardiovascular disease in HIV-infected individuals. PLoS One. 2012;7:e44454.
18. Nordell AD, McKenna M, Borges ÁH, Duprez D, Neuhaus J, Neaton JD. INSIGHT SMART, ESPRIT Study Groups; SILCAAT Scientific Committee. Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation. J Am Heart Assoc. 2014;3:e000844.
19. Longenecker CT, Funderburg NT, Jiang Y, et al. Markers of inflammation and CD8 T-cell activation, but not monocyte activation, are associated with subclinical carotid artery disease in HIV-infected individuals. HIV Med. 2013;14:385-390.
20. Longenecker CT, Jiang Y, Orringer CE, et al. Soluble CD14 is independently associated with coronary calcification and extent of subclinical vascular disease in treated HIV infection. AIDS. 2014;28:969.
21. Burdo TH, Lo J, Abbara S, et al. Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients. J Infect Dis. 2011;204:1227-1236.
22. Kaelber DC, Foster W, Gilder J, et al. Patient characteristics associated with venous thromboembolic events: a cohort study using pooled electronic health record data. J Am Med Inform Assoc. 2012;19:965-972.
23. Al-Kindi SG, Oliveira GH. Prevalence of preexisting cardiovascular disease in patients with different types of Cancer: the unmet need for onco-cardiology. Mayo Clin Proc. 2015;91:81-83.
24. Pfefferle K, Gil K, Fening S, et al. Validation study of a pooled electronic healthcare database: the effect of obesity on the revision rate of total knee arthroplasty. Eur J Orthop Surg Traumatol. 2014;24:1625-1628.
25. Maradey-Romero C, Prakash R, Lewis S, et al. The 2011-2014 prevalence of eosinophilic oesophagitis in the elderly amongst 10 million patients in the United States. Aliment Pharmacol Ther. 2015;41:1016-1022.
26. Yurteri-Kaplan LA, Mete MM, St Clair C, et al. Practice patterns of general gynecologic surgeons versus gynecologic subspecialists for concomitant apical suspension during vaginal hysterectomy for uterovaginal prolapse. South Med J. 2015;108:17-22.
27. Ye Z, Smith C, Kullo IJ. Usefulness of red cell distribution width to predict mortality in patients with peripheral artery disease. The Am J Cardiol. 2011;107:1241-1245.
28. Jackson CE, Dalzell JR, Bezlyak V, et al. Red cell distribution width has incremental prognostic value to B-type natriuretic peptide in acute heart failure. Eur J Heart Fail. 2009;11:1152-1154.
29. Felker GM, Allen LA, Pocock SJ, et al. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM program and the Duke Databank. J Am Coll Cardiol. 2007;50:40-47.
30. Muhlestein JB, Lappe DL, Anderson JL, et al. Both initial red cell distribution width (RDW) and change in RDW during heart failure hospitalization are associated with length of hospital stay and 30-day outcomes. Int J Lab Hematol. 2016;38:328-337.
31. Skjelbakken T, Lappegård J, Ellingsen TS, et al. Red cell distribution width is associated with incident myocardial infarction in a general population: the Tromsø Study. J Am Heart Assoc. 2014;3:e001109.
32. Isik T, Uyarel H, Tanboga IH, et al. Relation of red cell distribution width with the presence, severity, and complexity of coronary artery disease. Coron Artery Dis. 2012;23:51-56.
33. Zalawadiya SK, Veeranna V, Panaich SS, et al. Red cell distribution width and risk of peripheral artery disease: analysis of National Health and Nutrition Examination Survey 1999-2004. Vasc Med. 2012;17: 155-163.
34. Gungor B, Ozcan KS, Erdinler I, et al. Elevated levels of RDW is associated with non-valvular atrial fibrillation. J Thromb Thrombolysis. 2014;37:404-410.
35. Evans TC, Jehle D. The red blood cell distribution width. J Emerg Med. 1991;9:71-74.
36. Semba RD, Patel KV, Ferrucci L, et al. Serum antioxidants and inflammation predict red cell distribution width in older women: the Women's Health and Aging Study I. Clin Nutr. 2010;29:600-604.
37. Gallego ML. Perez-Hernandez IA, Palacios R, et al. Red cell distribution width in patients with HIV infection. Open J Intern Med. 2012;2:7-10.